Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Vascular Pharmacology | journal | 0.816 Q2 | 108 | 42 | 200 | 2140 | 495 | 196 | 2.25 | 50.95 | |
2 | U.S. Pharmacist | trade journal | 0.118 Q4 | 12 | 168 | 428 | 2749 | 31 | 397 | 0.10 | 16.36 | |
3 | Trends in Medical Research (discontinued) | journal | 0.146 Q3 | 11 | 14 | 25 | 428 | 18 | 25 | 1.07 | 30.57 | |
4 | Toxicology and Applied Pharmacology | journal | 1.601 Q1 | 189 | 292 | 972 | 15369 | 4577 | 944 | 4.88 | 52.63 | |
5 | Toxicologic Pathology | journal | 0.869 Q2 | 124 | 120 | 339 | 4800 | 880 | 308 | 2.32 | 40.00 | |
6 | Topics in antiviral medicine | journal | 3.076 Q1 | 46 | 21 | 57 | 544 | 322 | 57 | 5.71 | 25.90 | |
7 | Therapeutic Innovation and Regulatory Science | journal | 0.100 Q4 | 51 | 145 | 417 | 1971 | 133 | 405 | 0.25 | 13.59 | |
8 | Therapeutic Drug Monitoring | journal | 0.921 Q2 | 102 | 104 | 348 | 3205 | 1118 | 340 | 2.83 | 30.82 | |
9 | Strategies and Tactics in Organic Synthesis | book series | 0.240 Q3 | 10 | 0 | 15 | 0 | 4 | 13 | 0.00 | 0.00 | |
10 | Steroids | journal | 0.925 Q2 | 114 | 213 | 471 | 8881 | 1490 | 466 | 3.05 | 41.69 | |
11 | Research Journal of Toxins (discontinued) | journal | 0.331 Q3 | 4 | 0 | 2 | 0 | 4 | 2 | 2.00 | 0.00 | |
12 | Research Journal of Environmental Toxicology (discontinued) | journal | 0.265 Q3 | 19 | 39 | 54 | 1631 | 46 | 54 | 0.85 | 41.82 | |
13 | Research in Social and Administrative Pharmacy | journal | 0.737 Q1 | 69 | 42 | 115 | 1623 | 195 | 101 | 1.61 | 38.64 | |
14 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.103 Q4 | 40 | 0 | 6 | 0 | 0 | 6 | 0.00 | 0.00 | |
15 | Reproductive Toxicology | journal | 1.138 Q1 | 129 | 140 | 371 | 6399 | 1361 | 347 | 3.46 | 45.71 | |
16 | Regulatory Toxicology and Pharmacology | journal | 0.865 Q2 | 123 | 144 | 437 | 6615 | 1135 | 397 | 2.73 | 45.94 | |
17 | Reading Teacher | journal | 0.639 Q2 | 60 | 89 | 246 | 1572 | 228 | 239 | 0.78 | 17.66 | |
18 | Psychopharm Review | trade journal | 0.163 Q3 | 5 | 12 | 24 | 518 | 9 | 24 | 0.38 | 43.17 | |
19 | Prostaglandins and Other Lipid Mediators | journal | 0.951 Q2 | 86 | 46 | 142 | 2478 | 372 | 140 | 2.88 | 53.87 | |
20 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 1.337 Q1 | 150 | 292 | 936 | 18526 | 2928 | 701 | 2.78 | 63.45 | |
21 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.118 Q4 | 29 | 11 | 18 | 591 | 7 | 0 | 0.40 | 53.73 | |
22 | Proceedings of the Western Pharmacology Society | journal | 0.119 Q4 | 25 | 23 | 71 | 449 | 15 | 71 | 0.10 | 19.52 | |
23 | PPAR Research | journal | 0.929 Q2 | 59 | 19 | 215 | 948 | 480 | 202 | 1.78 | 49.89 | |
24 | PLoS Neglected Tropical Diseases | journal | 2.011 Q1 | 163 | 444 | 750 | 19699 | 3956 | 707 | 5.10 | 44.37 | |
25 | Pharmacy Times | trade journal | 0.103 Q4 | 8 | 187 | 614 | 1027 | 16 | 549 | 0.02 | 5.49 | |
26 | Pharmacopeial Forum (discontinued) | journal | 0.504 Q2 | 20 | 17 | 65 | 72 | 49 | 55 | 0.84 | 4.24 | |
27 | Pharmacology Biochemistry and Behavior | journal | 1.138 Q1 | 148 | 268 | 736 | 16615 | 2274 | 731 | 2.86 | 62.00 | |
28 | Pharmacology and Therapeutics | journal | 3.411 Q1 | 233 | 101 | 299 | 18833 | 3024 | 296 | 9.74 | 186.47 | |
29 | Pharmacological Reviews | journal | 10.386 Q1 | 254 | 33 | 59 | 10674 | 1354 | 59 | 21.41 | 323.45 | |
30 | Pharmacological Research | journal | 1.488 Q1 | 169 | 164 | 371 | 8777 | 1774 | 357 | 5.09 | 53.52 | |
31 | Pharmacogenetics and Genomics | journal | 1.315 | 152 | 112 | 332 | 4614 | 1395 | 327 | 3.96 | 41.20 | |
32 | Pharmaceutical Technology Europe | journal | 0.127 Q4 | 19 | 119 | 375 | 382 | 39 | 311 | 0.11 | 3.21 | |
33 | Pharmaceutical Technology | journal | 0.271 Q2 | 42 | 247 | 566 | 967 | 137 | 453 | 0.25 | 3.91 | |
34 | Pharmaceutical Research | journal | 1.678 Q1 | 229 | 277 | 809 | 13395 | 4037 | 766 | 4.68 | 48.36 | |
35 | Pharmaceutical Processing | trade journal | 0.119 Q4 | 4 | 44 | 108 | 44 | 8 | 87 | 0.07 | 1.00 | |
36 | Pharmaceutical Outsourcing | journal | 0.154 Q3 | 7 | 37 | 126 | 291 | 19 | 119 | 0.16 | 7.86 | |
37 | Pharmaceutical Formulation and Quality | trade journal | 0.100 Q4 | 1 | 40 | 49 | 329 | 0 | 43 | 0.00 | 8.23 | |
38 | Pharmaceutical Engineering | journal | 0.152 Q3 | 18 | 61 | 136 | 290 | 21 | 123 | 0.19 | 4.75 | |
39 | Pharmaceutical Development and Technology | journal | 0.485 Q2 | 70 | 71 | 210 | 2233 | 285 | 206 | 1.38 | 31.45 | |
40 | Pharmaceutical Chemistry Journal | journal | 0.147 Q4 | 39 | 168 | 459 | 2688 | 136 | 457 | 0.27 | 16.00 | |
41 | PDA Journal of Pharmaceutical Science and Technology | journal | 0.315 Q2 | 43 | 84 | 170 | 1419 | 135 | 156 | 0.68 | 16.89 | |
42 | Pain | journal | 2.740 Q1 | 296 | 451 | 1160 | 18754 | 6621 | 907 | 5.18 | 41.58 | |
43 | Nucleic Acid Therapeutics | journal | 1.071 Q1 | 77 | 49 | 110 | 1963 | 336 | 110 | 2.97 | 40.06 | |
44 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 8 | 22 | 911 | 0 | 22 | 0.00 | 113.88 | ||
45 | NTP Technical Report on the Toxicity Studies Series | book series | 6 | 2 | 0 | 186 | 0 | 0 | 0.00 | 93.00 | ||
46 | Neurotoxicology and Teratology | journal | 0.988 Q2 | 111 | 89 | 172 | 4937 | 591 | 167 | 3.41 | 55.47 | |
47 | Neurotoxicity Research | journal | 1.439 Q1 | 84 | 97 | 202 | 6297 | 742 | 198 | 3.70 | 64.92 | |
48 | Neuropsychopharmacology Reports | journal | 22 | 12 | 3 | 0 | 0 | 2 | 0.00 | 0.00 | ||
49 | Neuromethods | book series | 0.185 Q2 | 24 | 300 | 140 | 19806 | 63 | 127 | 0.45 | 66.02 | |
50 | Natural Product Communications | journal | 0.451 Q3 | 63 | 433 | 1113 | 10763 | 1309 | 1094 | 1.34 | 24.86 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®